Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility
2003 StandoutNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients
1992
Infective Endocarditis
2005 Standout
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
2008 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics
1999
Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule.
1994
Long-term, totally implantable central venous access ports connected to a Groshong atheter for chemotherapy of solid tumours: Experience from 178 cases using a single type of device
1997
A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia
1998
Beta-Lactam Antibiotic Therapy in Febrile Granulocytopenic Patients
1991
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Nasal Carriage as a Source ofStaphylococcus aureusBacteremia
2001 Standout
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients
2003
Antimicrobial therapy of unexplained fever in neutropenic patients
2003
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
2004
Imipenem - Cilastatin versus Sulbactam - Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients
1999
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study
2003
Diagnosis of Venous Access Port--Related Infections
1999
Bacteremic Pneumonia in Neutropenic Patients With Cancer
1998
Antithrombotic Therapy for VTE Disease
2016 Standout
Stopping Antibiotic Therapy in Neutropenic Patients
1988
Melioidosis
2003 Standout
Mitochondrial toxicity of antiviral drugs
1995
Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram‐Positive Bacterial Infections
2004
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Approach to the Patient with Prolonged Granulocytopenia
1993
Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy
1987
AIDS DEMENTIA COMPLEX
1999
Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient
1996
Inducible -Lactamases: Clinical and Epidemiologic Implications for Use of Newer Cephalosporins
1988
A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children
1995
Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-Neutropenic cancer patients
1997
Antithrombotic Therapy for VTE Disease
2012 Standout
Home treatment of febrile neutropenia: An empirical oral antibiotic regimen
1991
Early Discharge Of Pediatric Febrile Neutropenic Cancer Patients By Substitution Of Oral For Intravenous Antibiotics
1994
Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients
1993
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1997
EXPERIENCE WITH CEFEPIME VERSUS MEROPENEM AS EMPIRIC MONOTHERAPY FOR NEUTROPENIA AND FEVER IN PEDIATRIC PATIENTS WITH SOLID TUMORS
2006
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
2005
Effect of Nurse Staffing and Antimicrobial-Impregnated Central Venous Catheters on the Risk for Bloodstream Infections in Intensive Care Units
2003
A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer Chemotherapy
1999
Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with Cancer
1988
Chemotherapy and the war on cancer
2005 Standout
Venographic surveillance of tunneled venous access devices in adult oncology patients
1995
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients
2000
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients
1996
Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical Trials
1997
Is Monotherapy for Febrile Neutropenia Still a Viable Alternative?
1999
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients
1997
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Cefepime as Empirical Monotherapy in Febrile Patients with Hematological Malignancies and Neutropenia: A Randomized, Single-Center Phase II Trial
1999
Prevention of Venous Thromboembolism
2004 Standout
Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer
1997
Short Courses of Intravenous Empirical Antibiotic Treatment in Selected Febrile Neutropenic Children with Cancer
2002
Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.
1992
A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia
2000
HIV as the cause of AIDS
1996 StandoutNobel
Klebsiella pneumoniae bacteraemia at an urban general hospital
1990
Vancomycin as Part of Initial Empirical Antibiotic Therapy for Febrile Neutropenia in Patients with Cancer: Pros and Cons
1999
A Multicenter, Double‐Blind, Placebo‐Controlled Trial Comparing Piperacillin‐Tazobactam with and without Amikacin as Empiric Therapy for Febrile Neutropenia
2001
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients
1998
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
1993
Complement
2001 Standout
Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients
1997
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients
1988
Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy
2003
Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter
2003
HALVING OF MORTALITY OF SEVERE MELIOIDOSIS BY CEFTAZIDIME
1989
Recent Experience With Pseudomonas aeruginosa Bacteremia in Patients With Cancer
2000
Child development: risk factors for adverse outcomes in developing countries
2007 Standout
Catheter-related infection: An update on diagnosis, treatment, and prevention
1998
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series
1997
Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trial
1995
Totally implantable central venous access ports for long-term chemotherapy A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days
1998 Standout
Comparison of Amphotericin B Lipid Complex (ABLC) vs. AmBisome in the Treatment of Suspected or Documented Fungal Infections in Patients with Leukemia
2001
Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters
1995
Neutrophils in cancer: neutral no more
2016 Standout
Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients
1989
Importance of Candida Species Other than C. albicans as Pathogens in Oncology Patients
1995
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
2005
Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia
1992
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Treatment of febrile neutropenic patients with cancer who require hospitalization
2003
Vancomycin does not benefit persistently febrile neutropenic people with cancer
2004
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
Human Immunodeficiency Virus Infection and AIDS in a Person with Negative Serology
1997 StandoutNobel
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
2007 Standout
The treatment of febrile neutropenia: from the Dark Ages to the present
1997
From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1990
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
A prospective study comparing vancomycin and teicoplanin as second‐line empiric therapy for infection in neutropenic patients
1990
β-Lactam regimens for the febrile neutropenic patient
1990
An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients
1995
Randomized, Double-Blind, Multicenter Trial Comparing Clinafloxacin with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients
2001
Plasma HIV-1 Viremia in HIV-1 Infected Individuals Assessed by Polymerase Chain Reaction
1992
Assessment of Measuring Circulating Levels of Interleukin‐6, Interleukin‐8, C‐Reactive Protein, Soluble Fcy Receptor Type III, and Mannose‐Binding Protein in Febrile Children with Cancer and Neutropenia
1999
Fever of Unknown Origin in Febrile Leukopenia
2007
Emergence of Vancomycin Resistance inStaphylococcus aureus
1999
Ventilator-associated Pneumonia
2002 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study
1992
Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts.
1993
Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
1991
Regional Thrombolysis with Urokinase for Central Venous Catheter-related Thrombosis in Patients Undergoing High-dose Chemotherapy with Autologous Blood Stem Cell Rescue
1999
Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial
2000
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
How should imipenem-cilastatin be Used in the treatment of fever and infection in neutropenic cancer patients?
1998
The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis
1996
Resistance of enterococci to glycopeptides
1990
Persistent Fever After Recovery From Granulocytopenia in Acute Leukemia
1988
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group
1991
Antibiotic Streamlining From Combination Therapy to Monotherapy Utilizing an Interdisciplinary Approach
1988
Granulocytopenia and cancer therapy: Past problems, current solutions, future challenges
1984
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program
1996
Prevention and Treatment of Cancer-Related Infections
2012
Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients
1997
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Transferable vancomycin and teicoplanin resistance in Enterococcus faecium
1989
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients
1992
INTRAPERITONEAL CHEMOTHERAPY
1994
Ceftazidime Plus Amikacin Versus Ceftazidime Plus Vancomycin as Empiric Therapy in Febrile Neutropenic Children with Cancer
1991
Children and Adolescents Living with HIV and AIDS: A Review
2000
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Empirical Antimicrobial Therapy for Febrile Granulocytopenic Cancer Patients: Lessons from Four EORTC Trials
1988
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors
1991
Pathogenesis of human immunodeficiency virus infection
1993
Time to Clinical Response: An Outcome of Antibiotic Therapy of Febrile Neutropenia With Implications for Quality and Cost of Care
2000
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer
1995
Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients With Febrile Neutropenia
2008
Viral dynamics in human immunodeficiency virus type 1 infection
1995 StandoutNature
Empiric Monotherapy for Febrile Neutropenia - a Randomized Study Comparing Meropenem with Ceftazidime
1998
The Crisis in Antibiotic Resistance
1992 StandoutScience
Growth Factors and Cancer
1991 StandoutScience
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
1992
Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer)
1998
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity
1991
Guidelines for Treatment of Candidiasis
2004 Standout
Bacillus cereus and related species
1993 Standout
A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma
1992
Phylogenetic Perspectives in Innate Immunity
1999 StandoutScienceNobel
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
2001 Standout
Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination
1993
STAPHYLOCOCCUS AUREUS BACTEREMIA AND ENDOCARDITIS
1993
The Medical Course of Cancer Patients With Fever and Neutropenia
1988
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Creatine and Creatinine Metabolism
2000 Standout
Works of Janet Gress being referenced
Empiric Therapy with Amphotericin B in Febrile Granulocytopenic Patients
1991
Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection
1991
A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients.
1992
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
1995
Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
1991
A Randomized Trial Comparing Ceftazidime Alone With Combination Antibiotic Therapy in Cancer Patients With Fever and Neutropenia
1987
Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population
1987
Gram-Positive Infections and the Use of Vancomycin in 550 Episodes of Fever and Neutropenia
1988
A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia
1986
Approaching the controversies in antibacterial management of cancer patients
1984